化学療法の世界市場レポート 2024年

化学療法の市場規模は近年急速に拡大しています。2023年の308億9,000万米ドルから2024年には343億8,000万米ドルへと、CAGR11.3％で成長します。過去の期間において、化学療法の成長はいくつかの要因に起因しています。例えば、がん罹患率の増加、がん診断技術の進歩、より効果的な治療法の創出を促進する医薬品開発の革新、新たな治療法の発見につながる臨床試験活動の活発化、より多くの患者が治療を受けられるようになった医療へのアクセスの改善、がんとその治療法に対する理解と認知を高める啓発キャンペーンなどが挙げられます。

化学療法市場の成長軌道は、ヘルスケア支出の増加によってさらに加速しています。ヘルスケア支出には、医療品、個人的ヘルスケア、長期ケア、公衆衛生サービスなど、ヘルスケア商品およびサービスに対する金銭的支出が含まれます。ヘルスケア支出は、ヘルスケアシステムの重要な要素であり、ヘルスケアサービスを提供するために不可欠なリソースを供給しています。ヘルスケア支出の増加は、化学療法関連のソリューションやサービスの拡大を促進し、医療施設や高度な治療へのアクセスを容易にします。2023年5月に英国国家統計局が発表した報告書によると、2020年から2021年にかけてのヘルスケア支出は名目で9.4％、実質で9.7％増加することが明らかになった。2021年の予防医療への割り当ては457億2,000万米ドルに達し、前年の2倍以上に増加しました。したがって、ヘルスケア支出の増加が化学療法市場の成長を後押ししています。

2023年の化学療法市場で最大の地域は北米です。アジア太平洋は、化学療法市場レポートにおいて予測期間中に最も急成長する地域となる見込みです。化学療法市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 化学療法市場の特徴

第3章 化学療法市場の動向と戦略

第4章 化学療法市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の化学療法市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 化学療法市場セグメンテーション

• 世界の化学療法市場、製品タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• ポンプ
• カニューレ
• カテーテル
• その他の製品タイプ
• 世界の化学療法市場、サービス別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 血液がん
• 咽喉がん
• 肺がん
• 卵巣がん
• 胃がん
• 世界の化学療法市場、薬剤別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• アルキル化剤
• 代謝拮抗物質
• 抗腫瘍抗生物質
• トポイソメラーゼ阻害剤
• 有糸分裂阻害剤
• その他の薬剤
• 世界の化学療法市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 静脈内
• 世界の化学療法市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院
• 研究機関
• その他のエンドユーザー

第7章 化学療法市場の地域および国分析

• 世界の化学療法市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の化学療法市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋の化学療法市場

第9章 中国の化学療法市場

第10章 インドの化学療法市場

第11章 日本の化学療法市場

第12章 オーストラリアの化学療法市場

第13章 インドネシアの化学療法市場

第14章 韓国の化学療法市場

第15章 西欧の化学療法市場

第16章 英国の化学療法市場

第17章 ドイツの化学療法市場

第18章 フランスの化学療法市場

第19章 イタリアの化学療法市場

第20章 スペインの化学療法市場

第21章 東欧の化学療法市場

第22章 ロシアの化学療法市場

第23章 北米の化学療法市場

第24章 米国の化学療法市場

第25章 カナダの化学療法市場

第26章 南米化学療法市場

第27章 ブラジルの化学療法市場

第28章 中東の化学療法市場

第29章 アフリカの化学療法市場

第30章 化学療法市場の競合情勢と企業プロファイル

• 化学療法市場の競合情勢
• 化学療法市場の企業プロファイル
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Pfizer Inc.

第31章 世界の化学療法市場の競合ベンチマーキング

第32章 世界の化学療法市場の競争ダッシュボード

第33章 化学療法市場における主要な合併と買収

第34章 化学療法市場の将来展望と可能性分析

第35章 付録

“Chemotherapy Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chemotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chemotherapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The chemotherapy market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product Type: Pump; Cannula; Catheter; Other Product Types
• 2) By Service: Blood Cancer; Throat Cancer; Lung Cancer; Ovarian Cancer; Stomach Cancer
• 3) By Drugs: Alkylating Agents; Antimetabolites; Anti-Tumor Antibiotics; Topoisomerase Inhibitors; Mitotic Inhibitors; Other Drugs
• 4) By Route Of Administration: Oral; Intravenous
• 5) By End User: Hospitals; Research Institutes; Other End Users
• Companies Mentioned: GlaxoSmithKline plc; Eli Lilly and Company; F. Hoffmann-La Roche Ltd.; Novartis AG; Pfizer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Chemotherapy is a treatment method that employs powerful drugs or medications to target and eliminate fast-growing cells in the body. These drugs are instrumental in killing cancer cells, which proliferate at an accelerated rate. Chemotherapy can involve using drugs individually or in combination to effectively treat various types of cancer.

The primary product types associated with chemotherapy include pumps, cannulas, catheters, and other related equipment. Chemotherapy infusion pumps are devices attached to the patient, delivering controlled doses of drugs gradually into the bloodstream. Services related to chemotherapy encompass treatments for specific types of cancer, such as blood cancer, throat cancer, lung cancer, ovarian cancer, stomach cancer, among others. These treatments typically involve a range of drugs including alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and other medications administered through oral and intravenous routes. Chemotherapy services are primarily utilized by hospitals, research institutes, and other related healthcare facilities.

The chemotherapy market research report is one of a series of new reports from The Business Research Company that provides chemotherapy optical components market statistics, including chemotherapy optical components industry global market size, regional shares, competitors with a chemotherapy optical components market share, detailed chemotherapy optical components market segments, market trends and opportunities, and any further data you may need to thrive in the chemotherapy optical components industry. This chemotherapy optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chemotherapy market size has grown rapidly in recent years. It will grow from $30.89 billion in 2023 to $34.38 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. During the historical period, the growth in chemotherapy can be attributed to several factors. These include the increase in cancer incidence rates, advancements in cancer diagnosis techniques, innovations in drug development facilitating the creation of more effective treatments, heightened clinical trial activity leading to the discovery of new therapies, improved access to healthcare allowing more patients to receive treatment, and awareness campaigns increasing understanding and recognition of cancer and its treatments.

The chemotherapy market size is expected to see rapid growth in the next few years. It will grow to $54.86 billion in 2028 at a compound annual growth rate (CAGR) of 12.4%. Anticipated growth in the upcoming period within chemotherapy is expected to be influenced by several factors. These include the integration of immunotherapy into treatment methodologies, increased adoption of biosimilar drugs, growth in emerging markets, the utilization of genomic profiling for more targeted treatments, advancements in supportive care for better patient outcomes, and regulatory facilitation to streamline treatment protocols. Key trends projected in the forecast period encompass the implementation of digital health solutions in cancer care, the advancement of personalized medicine tailored to individual patient needs, ongoing research in the field of oncology, the integration of Artificial Intelligence (AI) for improved diagnostics and treatment planning, developments in nanotechnology for targeted therapies, and the trend towards home-based administration of chemotherapy for enhanced patient comfort and convenience.

The anticipated rise in cancer prevalence is poised to drive growth in the chemotherapy market. Cancer, characterized by uncontrolled cell growth and dissemination, necessitates the use of potent chemicals, either in combination or individually, to eliminate rapidly proliferating cancer cells. The escalating incidence of cancer is expected to amplify the demand for chemotherapy. For instance, projections from the American Cancer Society Inc. indicate an expected 1.9 million new cancer cases in the US in 2023, marking an increase from 1.8 million cases diagnosed in 2020. The corresponding forecast for cancer-related deaths in 2023 is 609,820, compared to 606,520 in 2020. Consequently, the rising prevalence of cancer is a driving force in the chemotherapy market.

The growth trajectory of the chemotherapy market is further fueled by an upswing in healthcare spending. Healthcare spending encompasses the financial outlay on healthcare goods and services, spanning medical items, personal healthcare, long-term care, and public health services. It stands as a crucial element of healthcare systems, supplying essential resources for delivering healthcare services. Increased healthcare spending augments the expansion of chemotherapy-related solutions and services, facilitating access to medical facilities and advanced treatments. Notably, a report from the UK's Office for National Statistics in May 2023 revealed a nominal and real increase of 9.4% and 9.7%, respectively, in healthcare spending between 2020 and 2021. The allocation for preventive care in 2021 reached $45.72 billion, more than doubling from the previous year. Hence, heightened healthcare spending propels the chemotherapy market's growth.

Leading players in the chemotherapy market are strategically concentrating on the introduction of innovative solutions, such as chemotherapy infusion pumps, to establish a competitive advantage. Chemotherapy infusion pumps are devices designed to deliver chemotherapy drugs directly into the bloodstream through an IV line. These pumps enable controlled administration, ensuring a gradual and steady infusion of drugs into the body. A case in point is Shanghai MicroPort Lifesciences Co. Ltd., a China-based medical technology developer and manufacturer, which unveiled AutoEx, its independently developed chemotherapy infusion pump, in March 2022. In clinical applications, specialized infusion pumps are frequently employed for precise and continuous infusion to maintain optimal blood medication concentration during chemotherapy, enhancing anti-cancer cell activity while mitigating side effects. AutoEx, designed for intravenous medication administration, serves the purpose of flushing or sealing PICCs, CVCs, and ports during chemotherapy, offering both intermittent and continuous usage options.

Major players in the chemotherapy market are actively pursuing strategic partnerships as a key avenue to facilitate the commercialization of cutting-edge medical devices aimed at enhancing chemotherapy services. These collaborative ventures are designed to capitalize on the unique strengths and resources of each partner, expediting advancements in cancer treatment, elevating patient outcomes, and addressing unmet medical needs. A notable example occurred in March 2023 when EVERSANA, a US-based provider of global services to the life sciences industry, joined forces with ChemoMouthpiece LLC, a US-based medical device company. This collaboration was forged to support the launch and commercialization of the Chemo Mouthpiece, an innovative intraoral ice pack delivering cryotherapy to the oral cavity of chemotherapy patients. The device plays a crucial role in preventing and treating oral mucositis, a prevalent and painful side effect of chemotherapy.

In October 2021, Amgen Inc., a prominent US-based global biotechnology company, completed the acquisition of ChemoCentryx Inc. for a substantial $3.7 billion. This strategic acquisition is anticipated to bolster Amgen's portfolios in inflammation and nephrology by incorporating ChemoCentryx's TAVNEOS. Through this integration, the companies are poised to actively contribute to the expansion and innovation of advanced treatments, catering to patients grappling with severe diseases. ChemoCentryx, Inc., the acquired entity, is a US-based biopharmaceutical company specializing in the treatment of autoimmune diseases, inflammatory disorders, and cancer.

Major companies operating in the chemotherapy market report are GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc. .

North America was the largest region in the chemotherapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chemotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chemotherapy market includes revenues earned by entities by providing corticosteroids and hormonal agents as chemotherapy drugs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Chemotherapy Market Characteristics

3. Chemotherapy Market Trends And Strategies

4. Chemotherapy Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Chemotherapy Market Size and Growth

• 5.1. Global Chemotherapy Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Chemotherapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Chemotherapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chemotherapy Market Segmentation

• 6.1. Global Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pump
• Cannula
• Catheter
• Other Product Types
• 6.2. Global Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Blood Cancer
• Throat Cancer
• Lung Cancer
• Ovarian Cancer
• Stomach Cancer
• 6.3. Global Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Alkylating Agents
• Antimetabolites
• Anti-Tumor Antibiotics
• Topoisomerase Inhibitors
• Mitotic Inhibitors
• Other Drugs
• 6.4. Global Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Intravenous
• 6.5. Global Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Research Institutes
• Other End Users

7. Chemotherapy Market Regional And Country Analysis

• 7.1. Global Chemotherapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Chemotherapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chemotherapy Market

• 8.1. Asia-Pacific Chemotherapy Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chemotherapy Market

• 9.1. China Chemotherapy Market Overview
• 9.2. China Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chemotherapy Market

• 10.1. India Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chemotherapy Market

• 11.1. Japan Chemotherapy Market Overview
• 11.2. Japan Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chemotherapy Market

• 12.1. Australia Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chemotherapy Market

• 13.1. Indonesia Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chemotherapy Market

• 14.1. South Korea Chemotherapy Market Overview
• 14.2. South Korea Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chemotherapy Market

• 15.1. Western Europe Chemotherapy Market Overview
• 15.2. Western Europe Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chemotherapy Market

• 16.1. UK Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chemotherapy Market

• 17.1. Germany Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chemotherapy Market

• 18.1. France Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chemotherapy Market

• 19.1. Italy Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chemotherapy Market

• 20.1. Spain Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chemotherapy Market

• 21.1. Eastern Europe Chemotherapy Market Overview
• 21.2. Eastern Europe Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chemotherapy Market

• 22.1. Russia Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chemotherapy Market

• 23.1. North America Chemotherapy Market Overview
• 23.2. North America Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chemotherapy Market

• 24.1. USA Chemotherapy Market Overview
• 24.2. USA Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chemotherapy Market

• 25.1. Canada Chemotherapy Market Overview
• 25.2. Canada Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chemotherapy Market

• 26.1. South America Chemotherapy Market Overview
• 26.2. South America Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chemotherapy Market

• 27.1. Brazil Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chemotherapy Market

• 28.1. Middle East Chemotherapy Market Overview
• 28.2. Middle East Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chemotherapy Market

• 29.1. Africa Chemotherapy Market Overview
• 29.2. Africa Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chemotherapy Market Competitive Landscape And Company Profiles

• 30.1. Chemotherapy Market Competitive Landscape
• 30.2. Chemotherapy Market Company Profiles
  • 30.2.1. GlaxoSmithKline plc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Eli Lilly and Company
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. F. Hoffmann-La Roche Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Novartis AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Pfizer Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Chemotherapy Market Competitive Benchmarking

32. Global Chemotherapy Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Chemotherapy Market

34. Chemotherapy Market Future Outlook and Potential Analysis

• 34.1 Chemotherapy Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Chemotherapy Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Chemotherapy Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer